Abacus Life Targets Close of the Acquisition of Carlisle Management Company S.C.A. for December 2, 2024 with Receipt of Regulatory Non-Objection

Core Viewpoint - Abacus Life, Inc. has received regulatory nonobjection from the Luxembourg CSSF for the acquisition of Carlisle Management Company, which will significantly enhance its asset management capabilities in the life settlement space [1][2]. Company Overview - Abacus Life is a pioneering global alternative asset manager specializing in uncorrelated financial products, leveraging longevity data and actuarial technology to create high-return investment opportunities [3][4]. - The company currently manages nearly $3 billion in assets, including pending acquisitions, and is the only publicly traded firm focused on lifespan-based financial products [4]. Acquisition Details - The acquisition of Carlisle Management Company is expected to add approximately$2.0 billion in assets under management to Abacus's ABL Wealth division [2]. - Carlisle has been a leader in the life settlement industry since 2008, known for its transparent transactions and integrity, and is licensed as an Alternative Investment Fund Manager under the CSSF [2][7]. Strategic Growth Areas - Abacus is expanding its expertise in longevity and lifespan into new growth areas, including: - ABL Wealth, which offers longevity-based wealth management platforms for financial advisors [5]. - ABL Tech, a technology service providing advanced real-time data tracking and analysis for various financial entities [5][6]. Industry Position - The acquisition of Carlisle is viewed as a major milestone for Abacus in expanding its global alternative asset management footprint, enhancing its position in the life settlement market [2].